Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2022 Earnings Call. As a reminder, today's conference call is being recorded.
Posts Tagged ‘NASDAQ:SRPT’
5 Best Healthcare Stocks For Recession
McKesson Corporation (NYSE:MCK) is one of the most notable healthcare companies in the US.
5 Best Genomics Stocks To Buy Now
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Top 10 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 10 stock picks of Eli Casdin's Casdin Capital.
10 Best Pharma Stocks To Buy Now
With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.
5 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management
In this piece we will take a look at the top five healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management. If you want to learn about Mr.
Hedge Funds Are Souring On Sarepta Therapeutics Inc (SRPT)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
5 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at the 5 biotech and pharma stocks to buy according to billionaire Steve Cohen. If you want to check out more stocks and learn about Mr.
Hedge Fund and Insider Trading News: Dalton Investments, Balyasny Asset Management, Livermore Partners, IsZo Capital Management, Sarepta Therapeutics Inc (SRPT), Tabula Rasa HealthCare Inc (TRHC), and More
Dalton Investments, a $3.4 billion U.S. investment firm, says it’s still on the fence over whether to support Shinsei Bank Ltd.’s management or SBI Holdings Inc.
5 Stocks Cathie Wood is Selling
In this article, we discuss Tesla and the 4 other stocks that Cathie Wood is selling.
11 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 11 best genomic stocks to buy now.
Should I Buy Sarepta Therapeutics Inc (SRPT)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Cathie Wood is Getting Rid of These 10 Stocks
In this article, we discuss the 10 stocks Cathie Wood is getting rid of.
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Here’s Why Artisan Partners Disposed its Sarepta Therapeutics Inc. (SRPT) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded...
Is SRPT Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is SRPT A Good Stock To Buy Now According To Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Sarepta Therapeutics Inc (SRPT): Are Hedge Funds Right About This Stock?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Sarepta Therapeutics Inc (SRPT) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Is Sarepta Therapeutics Inc (SRPT) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Do Hedge Funds Love Sarepta Therapeutics Inc (SRPT)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
How Did Sarepta Therapeutics Inc (SRPT) Compare Against Top Hedge Fund Stocks in 2019?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Did Hedge Funds Drop The Ball On Sarepta Therapeutics Inc (SRPT) ?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money ...
Hedge Funds Have Never Been This Bullish On Sarepta Therapeutics Inc (SRPT)
Is Sarepta Therapeutics Inc (NASDAQ:SRPT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Here’s What Hedge Funds Think About Sarepta Therapeutics Inc (SRPT)
Is Sarepta Therapeutics Inc (NASDAQ:SRPT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Here is What Hedge Funds Think About Sarepta Therapeutics Inc (SRPT)
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Is Sarepta Therapeutics Inc (SRPT) A Good Stock To Buy?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Hedge Funds Just Stormed Into This Red-Hot Biotech Company
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
The 25 Biggest Insider Purchases in October
Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January 2016.
Here’s What Is Going On In The Financial Markets Today?
"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.
Why Sarepta Therapeutics Inc (SRPT) Shares Are Surging
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to 'Buy' from 'Hold' and set a $45 target price.
What Do Hedge Funds Think of Sarepta Therapeutics Inc (SRPT)?
In a rather quiet market where the Dow is down but the S&P and NASDAQ are both up, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have rallied 3%, showing some solid relative...
Sarepta Therapeutics Inc (SRPT) Gets Off To A Running Start With Eteplirsen
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the week’s biggest winners from the J.P.
Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
5 Medical Tech Stocks You Should Be Investing In
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know which stocks to choose...
Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
Joseph Edelman's Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being invested in healthcare stocks.
Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever
Jason Karp's Tourbillon Capital Partners has retaken a stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) after having sold off its previous position in the stock during the second...
Sarepta Therapeutics Inc (SRPT) Stock: “Eteplirsen Approval Controversy Rages On”
If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne muscular dystrophy.
Today’s Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More
After yesterday's rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this article, we analyze some stocks...
Why Sarepta Therapeutics, Ralph Lauren, Fifth Third Bancorp, and Two Other Stocks Are in Spotlight on Friday
WTI crude futures have sank below the $50 per barrel mark around noon as traders brace for another potential rise in the rig count.
Here’s Why These Five Stocks Are Trading Higher Today
Broad markets are shaky today with NASDAQ trading in red territory.
Rite Aid Corporation, WCI Communities & Other Stocks in Spotlight Following Earnings, M&A News and More
Wall Street is quiet today after the Federal Reserve's Wednesday decision of keeping interest rates the same.
Sarepta Soars to 150% Q3 Gains, Wal-Mart Closes Jet Deal, SeaWorld Sinks & More
Among the stocks capturing attention from traders early this morning are SeaWorld Entertainment Inc (NYSE:SEAS), Ascena Retail Group Inc (NASDAQ:ASNA), Wal-Mart Stores, Inc.
Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the NASDAQ inching up 0.4%.
Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today
Some stocks are nonetheless gaining ground this morning, including Sarepta Therapeutics Inc (NASDAQ:SRPT), At Home Group Inc.
